Vaccine Hesitancy (Lockwood 2024)
At the end of this session, learners will be able to review the current state of vaccine hesitancy, explore answers to common vaccine concerns, and…
At the end of this session, learners will be able to review the current state of vaccine hesitancy, explore answers to common vaccine concerns, and…
In this session, the current management of anaphylaxis is discussed, both in the acute ER setting, and upon discharge at home. The use of adjunctive…
Approximately 20% of systemic lupus erythematosus (SLE) develops prior to 18 years of age, and the diagnosis can take years. Please join us for an…
This Allergy and Immunology session will discuss the framework for diagnosing difficult to diagnose patients, how to analyze yield data, and the Undiagnosed Disease Program…
At the end of this session, learners will be able to discuss vaccine hesitancy in populations and how to combat hesitancy issues in order provide…
At the end of this session, learners will be able to discuss what happens when the five cardinal features of the immune system break down,…
At the end of this session, learners will be able to understand various pediatric medical cases pertaining to infectious diseases and discuss the differential diagnoses…
In Fall 2023, three new products became available to prevent RSV: a monoclonal antibody for infants and high-risk toddlers, a vaccine for pregnant women, and…
For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending…
E. John Wherry, PhD, is the Barbara and Richard Schiffrin President’s Distinguished Professor, Chair of the Department of Systems Pharmacology and Translational Therapeutics in the…